Big Pharma and biotech companies often outsource clinical trials to external companies. Startups offer services ranging from clinical trials recruitment to patient monitoring. Europe's early-stage ...

Europe, particularly France, is becoming less attractive to pharmaceutical companies conducting clinical trials due to excessive bureaucracy that delays processes, according to Leem (Les Entreprises ...

The European clinical trial landscape will take centre stage this October as leading voices from the biopharma and healthcare sectors convene in Copenhagen, Denmark, for the annual Outsourcing in ...

After a six-month beta testing period, the European Clinical Trials Information Network is rolling out its patient recruitment platform across Europe, the company announced in a Sept. 25 release. The ...

The aim of the EU Clinical Trials Regulation (CTR) is to harmonise the clinical trial regulation process across 27 countries and have an 80-day approval timeline, stated Dr. Martine Dehlinger-Kremer, ...

Accelerating Clinical Trials in the EU (ACT EU) is an initiative developed by the European Commission, Heads of Medicines Agencies and the European Medicines Agency to transform the clinical trials ...

As part of a lifecycle IP strategy for a therapeutic product, it can be important to protect inventions arising during the clinical development of the product. Disclosures made during the clinical ...

The European Clinical Trials Information Network (ClinicalTrials.EU) has today announced its official rollout across the continent. United Kingdom - October 4, 2024 — The patient-centric platform aims ...

The practice of medicine is constantly evolving, and medical practitioners and researchers around the world continue to develop and evaluate new ways to treat human illness. At any given time, ...

Biodexa Pharmaceuticals PLC has filed a Clinical Trial Application (CTA) with the European Medicines Agency (EMA) for its Phase 3 Serenta trial, aimed at patients with familial adenomatous polyposis ...